Post-earnings recap
Reported
Wed, Feb 27, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported an earnings per share of $0.27, significantly exceeding expectations. However, the stock fell by 2.63% in reaction to the earnings report. The lack of revenue details and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +304.18% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.